Standard Family Office LLC Bio Techne Corp Transaction History

Standard Family Office LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $128,099 - $178,511	397 Added 127.65%	708 $245,000
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $35,385 - $48,779	-100 Reduced 24.33%	311 $135,000
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $96,247 - $110,787	211 Added 105.5%	411 $213,000
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $527,170 - $638,572	-1,185 Reduced 85.56%	200 $97,000
Q2 2021 Aug 13, 2021	BUY	$387.35 - $450.26 $77,470 - $90,052	200 Added 16.88%	1,385 $624,000
Q1 2021 May 12, 2021	SELL	$314.62 - $411.0 $62,924 - $82,200	-200 Reduced 14.44%	1,185 $453,000
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $341,956 - $445,789	1,385 New	1,385 $440,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Standard Family Office LLC with notifications on news.